Upper Extremity Deep Vein Thrombosis: Risk Factors, Diagnosis, and Management

ABSTRACT

Upper extremity deep vein thrombosis (UEDVT) should no longer be regarded as an uncommon and benign disease, as previously reported. It is usually associated with risk factors, as central venous lines, malignancy, and coagulation defects; however, up to 20% of UEDVTs are apparently spontaneous. The clinical picture is characterized by swelling, pain, and functional impairment, albeit UEDVT may be completely asymptomatic. Objective testing is mandatory prior to instituting anticoagulation because the prevalence of UEDVT is less than 50% in symptomatic subjects, and compression ultrasound or color Doppler represents the preferred diagnostic methods. Up to 36% of the patients develop pulmonary embolism, which may be fatal; postthrombotic sequelae and recurrent thromboembolism are also frequent complications. Unfractionated or low-molecular-weight heparin followed by oral anticoagulation should be regarded as the treatment of choice; thrombolysis and surgery may be indicated in selected cases. Prophylaxis with low-dose heparin or low-dose warfarin is necessary whenever central venous catheters are positioned.

KEYWORD

Upper extremity deep vein thrombosis - compression ultrasonography - pulmonary embolism - postthrombotic syndrome - malignancy

REFERENCES

• 1 Hill S L, Berry R E. Subclavian vein thrombosis: a continuing challenge.  Surgery . 1990;  108 1-9
• 2 Prandoni P, Polistena P, Bernardi E. Upper extremity deep-vein thrombosis risk factors, diagnosis, and complications.  Arch Intern Med . 1997;  157 57-62
• 3 Hingorani A, Ascher E, Lorenson E. Upper extremity deep venous thrombosis and its impact on morbidity and mortality rates in a hospital-based population.  J Vasc Surg . 1997;  26 853-860
• 4 Becker D M, Philbrick J T, Walker F B. Axillary and subclavian venous thrombosis. Prognosis and treatment.  Arch Intern Med . 1991;  151 1934-1943
• 5 Hingorani A, Ascher E, Hanson J. Upper extremity versus lower extremity deep venous thrombosis.  Am J Surg . 1997;  174 214-217
• 6 Kooij J DB, van der Zant M F, van Beek J R E, Reekers J A. Pulmonary embolism in deep venous thrombosis of the upper extremity: more often in catheter-related thrombosis.  Neth J Med . 1997;  50 238-242
• 7 Coon W W, Willis P W. Thrombosis of axillary and subclavian veins.  Arch Surg . 1966;  94 657-663
• 8 Horattas M C, Wright D J, Fenton A H. Changing concepts of deep venous thrombosis of the upper extremity. Report of a series and review of the literature.  Surgery . 1988;  104 561-567
• 9 Lokich J J, Becker B. Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancy.  Cancer . 1983;  52 1586-1589
• 10 De Cicco M, Matovic M, Balestreri L. Central venous thrombosis: an early and frequent complication in cancer patients bearing long-term silastic catheter. A prospective study.  Thromb Res . 1997;  86 101-113
• 11 Martin C, Viviand X, Saux P, Gouin F. Upper-extremity deep vein thrombosis after central venous catheterization via the axillary vein.  Crit Care Med . 1999;  27 2626-2629
• 12 Marinella M A, Kathula S K, Markert R J. Spectrum of upper-extremity deep venous thrombosis in a community teaching hospital.  Heart Lung . 2000;  29 113-117
• 13 Heron E, Lozinguez O, Alhenc-Gelas M, Emmerich J, Fiessinger J N. Hypercoagulable states in primary upper-extremity deep vein thrombosis.  Arch Intern Med . 2000;  160 382-386
• 14 Hughes E SR. Venous obstruction in the upper extremity.  Br J Surg . 1949;  36 155-163
• 15 Ellis M H, Manor Y, Witz M. Risk factors and management of patients with upper limb deep vein thrombosis.  Chest . 2000;  117 43-46
• 16 Urschel H C, Razzuk M A. Paget-Schroetter syndrome: what is the best management?.  Ann Thor Surg . 2000;  69 1663-1668
• 17 Ninet J, Demolombe-Rague S, Bureau du Colombier P, Coppere B. Les thromboses veineuses profondes des membres supérieurs.  Sang Thrombose Vaisseaux . 1994;  6 103-114
• 18 Hood D B, Kuehne J, Yellin A E, Weaver F A. Vascular complications of thoracic outlet syndrome.  Am Surg . 1997;  63 913-917
• 19 Monreal M, Raventos A, Lerma R. Pulmonary embolism in patients with upper extremity DVT associated to venous central lines: a prospective study.  Thromb Haemost . 1994;  72 548-550
• 20 Timsit J F, Farkas J C, Boyer J M. Central vein catheter-related thrombosis in intensive care patients: incidence, risks factors, and relationship with catheter-related sepsis.  Chest . 1998;  114 207-213
• 21 Girolami A, Prandoni P, Zanon E, Bagatella P, Girolami B. Venous thromboses of upper limbs are more frequently associated with occult cancer as compared with those of lower limbs.  Blood Coagul Fibrinol . 1999;  10 455-457
• 22 Hammers L W, Cohn S M, Brown J M. Doppler color flow imaging surveillance of deep vein thrombosis in high-risk trauma patients.  J Ultrasound Med . 1996;  15 19-24
• 23 Martinelli I, Cattaneo M, Panzeri D, Taioli E, Mannucci P M. Risk factors for deep venous thrombosis of the upper extremities.  Ann Intern Med . 1997;  126 707-711
• 24 Linblad B, Tengblom L, Bergqvist D. Deep vein thrombosis of the axillary-subclavian veins: epidemiologic data, effects of different types of treatment and late sequelae.  Eur J Vasc Surg . 1988;  2 161-165
• 25 de Mola R L J, Kiwi R, Austin C, Goldfarb J M. Subclavian deep vein thrombosis associated with the use of recombinant follicle-stimulating hormone (Gonal-F) complicating mild ovarian hyperstimulation syndrome.  Fertil Steril . 2000;  73 1253-1255
• 26 Lisse J R, Davis C P, Thurmond-Anderle M. Cocaine abuse and deep venous thrombosis.  Ann Intern Med . 1989;  110 571-572
• 27 Ruggeri M, Castaman G, Tosetto A, Rodeghiero F. Low prevalence of thrombophilic coagulation defects in patients with deep vein thrombosis of the upper limbs.  Blood Coagul Fibrinol . 1997;  8 191-194
• 28 Provenzale J M, Ortel T L, Allen N B. Systemic thrombosis in patients with antiphospholipid antibodies. Lesion distribution and imaging findings.  AJR . 1998;  170 285-290
• 29 Horne M K, Mayo D J, Alexander H R. Upper extremity impedance plethysmography in patients with venous access devices.  Thromb Haemost . 1994;  72 540-542
• 30 Patwardhan N A, Anderson F A, Cutler B S, Wheeler H B. Noninvasive detection of axillary and subclavian venous thrombosis by impedance plethysmography.  J Cardiovasc Surg . 1983;  24 250-255
• 31 Zufferey C, Pararas C, Monti M, Depairon M. Assessment of acute and old deep venous thrombosis in upper extremity by venous strain gauge plethysmography.  Vasa . 1992;  21 263-267
• 32 Sottiurai V S, Towner K, McDonnell A E, Zarins C K. Diagnosis of upper extremity deep vein thrombosis using noninvasive technique.  Surgery . 1982;  91 582-585
• 33 Mukherjee D, Andersen C A, Sado A S, Bertoglio M. Use of light reflection rheography for diagnosis of axillary or subclavian venous thrombosis.  Am J Surg . 1991;  161 651-656
• 34 Knudson G J, Wiedmeyer D A, Erickson S J. Color Doppler sonographic imaging in the assessment of upper-extremity deep venous thrombosis.  AJR . 1990;  154 399-403
• 35 Baxter G M, Kincaid W, Jeffrey R F, Millar G M, Porteous C, Morley P. Comparison of color Doppler ultrasound with venography in the diagnosis of axillary and subclavian vein thrombosis.  Br J Radiol . 1991;  64 777-781
• 36 Elliott G. Upper-extremity deep vein thrombosis.  Lancet . 1997;  349 1188-1189
• 37 Fraser J D, Anderson D R. Deep venous thrombosis: recent advances and optimal investigation with US.  Radiology . 1999;  211 9-24
• 38 Fielding J R, Nagel J S, Pomeroy O. Upper extremity DVT: correlation of MR and nuclear medicine flow imaging.  Clin Imag . 1997;  21 260-263
• 39 Hicken G J, Ameli F M. Management of subclavian-axillary vein thrombosis: a review.  Can J Surg . 1998;  41 13-25
• 40 Savage K J, Wells P S, Schulz V. Outpatient use of low molecular weight heparin (Dalteparin) for the treatment of deep vein thrombosis of the upper extremity.  Thromb Haemost . 1999;  82 1008-1010
• 41 Adelman M A, Stone D H, Riles T S, Lamparello P J, Giangola G, Rosen R J. A multidisciplinary approach to the treatment of Paget-Schroetter syndrome.  Ann Vasc Surg . 1997;  11 149-154
• 42 Sheeran S R, Hallisey M J, Murphy T P, Faberman R S, Sherman S. Local thrombolytic therapy as part of a multidisciplinary approach to acute axillosubclavian vein thrombosis (Paget-Schroetter syndrome).  J Vasc Interv Radiol . 1997;  8 253-260
• 43 Haire W D, Atkinson J B, Stephens L C, Kotulak G D. Urokinase versus recombinant tissue plasminogen activator in thrombosed central venous catheters: a double-blinded, randomized trial.  Thromb Haemost . 1994;  72 543-547
• 44 Chang R, Horne M K, Mayo D J, Doppman J L. Pulse-spray treatment of subclavian and jugular venous thrombi with recombinant tissue plasminogen activator.  J Vasc Interv Radiol . 1996;  7 845-851
• 45 Spence L D, Gironta M G, Malde H M, Mickolick C T, Geisinger M A, Dolmatch B L. Acute upper extremity deep venous thrombosis: safety and effectiveness of superior vena caval filters.  Radiology . 1999;  210 53-58
• 46 Ascher E, Hingorani A, Mazzariol F, Jacob T, Yorkovich W, Gade P. Clinical experience with superior vena caval Greenfield filters.  J Endovasc Surg . 1999;  6 365-369
• 47 Monreal M, Lafoz E, Ruitz J, Valls R, Alastrue A. Upper-extremity deep venous thrombosis and pulmonary embolism. A prospective study.  Chest . 1991;  99 280-283
• 48 Kerr T M, Lutter K S, Moeller D M. Upper extremity venous thrombosis diagnosed by Duplex scanning.  Am J Surg . 1990;  160 202-206
• 49 Randolph A G, Cook D J, Gonzales C A, Andrew M. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis.  Chest . 1998;  113 165-171
• 50 Bern M M, Lokich J J, Wallach S R. Very low doses of warfarin can prevent thrombosis in central venous catheters.  Ann Intern Med . 1990;  112 423-428
• 51 Monreal M, Alastrue A, Rull M. Upper extremity deep venous thrombosis in cancer patients with venous access devices. Prophylaxis with a low molecular weight heparin (Fragmin).  Thromb Haemost . 1996;  75 251-253